Progress in hepatitis B: a 30-year journey through three continents
- PMID: 24619499
- PMCID: PMC4077917
- DOI: 10.1002/hep.27120
Progress in hepatitis B: a 30-year journey through three continents
Figures
References
-
- Lam KC, Lai CL, Trepo C, Wu PC. Deleterious effect of prednisolone in HBsAg-positive chronic active hepatitis. N Engl J Med. 1981;304:380–386. - PubMed
-
- Greenberg HB, Pollard RB, Lutwick LI, Gregory PB, Robinson WS, Merigan TC. Effect of human leukocyte interferon on hepatitis B virus infection in patients with chronic active hepatitis. N Engl J Med. 1976;295:517–522. - PubMed
-
- Lok AS, Weller IV, Karayiannis P, Brown D, Fowler MJ, Monjardino J, et al. Thrice weekly lymphoblastoid interferon is effective in inhibiting hepatitis B virus replication. Liver. 1984;4:45–49. - PubMed
-
- Smith CI, Kitchen LW, Scullard GH, Robinson WS, Gregory PB, Merigan TC. Vidarabine monophosphate and human leukocyte interferon in chronic hepatitis B infection. JAMA. 1982;247:2261–2265. - PubMed
-
- Hoofnagle JH, Minuk GY, Dusheiko GM, Schafer DF, Johnson R, Straus S, et al. Adenine arabinoside 5'-monophosphate treatment of chronic type B hepatitis. Hepatology. 1982;2:784–788. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources